250 related articles for article (PubMed ID: 33822317)
21. The future health and economic burden of obesity-attributable type 2 diabetes and liver disease among the working-age population in Saudi Arabia.
Coker T; Saxton J; Retat L; Alswat K; Alghnam S; Al-Raddadi RM; Abdul Razack HI; Webber L; Alqahtani SA
PLoS One; 2022; 17(7):e0271108. PubMed ID: 35834577
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
[TBL] [Abstract][Full Text] [Related]
23. Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database.
Terai S; Buchanan-Hughes A; Ng A; Lee IH; Hasegawa K
J Gastroenterol; 2021 Mar; 56(3):274-284. PubMed ID: 33496858
[TBL] [Abstract][Full Text] [Related]
24. Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany.
Canbay A; Kachru N; Haas JS; Meise D; Ozbay AB; Sowa JP
Ann Transl Med; 2021 Apr; 9(8):615. PubMed ID: 33987313
[TBL] [Abstract][Full Text] [Related]
25. Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study.
O'Hara J; Finnegan A; Dhillon H; Ruiz-Casas L; Pedra G; Franks B; Morgan G; Hebditch V; Jönsson B; Mabhala M; Reic T; Van Thiel I; Ratziu V; Romero-Gomez M; Bugianesi E; Schattenberg JM; Anstee QM
JHEP Rep; 2020 Oct; 2(5):100142. PubMed ID: 32775976
[TBL] [Abstract][Full Text] [Related]
26. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Fukusato T
World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
[TBL] [Abstract][Full Text] [Related]
27. Modelling the economic and clinical burden of non-alcoholic steatohepatitis in East Asia: Data from Hong Kong.
Tampi RP; Wong VW; Wong GL; Shu SS; Chan HL; Fung J; Stepanova M; Younossi ZM
Hepatol Res; 2020 Sep; 50(9):1024-1031. PubMed ID: 32537840
[TBL] [Abstract][Full Text] [Related]
28. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; McNeil R; Turner MJ; Han B; Provenzale D; Choi SS; Moylan CA; Hunt CM
Aliment Pharmacol Ther; 2018 Jan; 47(2):268-278. PubMed ID: 29115682
[TBL] [Abstract][Full Text] [Related]
30. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data.
Loomba R; Wong R; Fraysse J; Shreay S; Li S; Harrison S; Gordon SC
Aliment Pharmacol Ther; 2020 Jun; 51(11):1149-1159. PubMed ID: 32372515
[TBL] [Abstract][Full Text] [Related]
31. Hospitalization costs and risk of mortality in adults with nonalcoholic steatohepatitis: Analysis of a French national hospital database.
Boursier J; Shreay S; Fabron C; Torreton E; Fraysse J
EClinicalMedicine; 2020 Aug; 25():100445. PubMed ID: 32775971
[TBL] [Abstract][Full Text] [Related]
32. Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018.
Morgan A; Hartmanis S; Tsochatzis E; Newsome PN; Ryder SD; Elliott R; Floros L; Hall R; Higgins V; Stanley G; Cure S; Vasudevan S; Pezzullo L
Eur J Health Econ; 2021 Jun; 22(4):505-518. PubMed ID: 33751289
[TBL] [Abstract][Full Text] [Related]
33. Hemodialysis delivery, dialysis dose achievement, and vascular access types in hemodialysis patients from the Gulf Cooperation Council countries enrolled in the dialysis outcomes and practice patterns study phase 5 (2012-2015).
AlYousef A; AlGhareeb S; Al Wakeel J; Al-Ghamdi SM; Bieber BA; Hassan M; Al Maimani Y; Alkandari N; Ahmed HZ; Fawzy A; Pisoni RL;
Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):S42-50. PubMed ID: 27991478
[TBL] [Abstract][Full Text] [Related]
34. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
Massoud O; Charlton M
Clin Liver Dis; 2018 Feb; 22(1):201-211. PubMed ID: 29128057
[TBL] [Abstract][Full Text] [Related]
35. Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies.
Oda K; Uto H; Mawatari S; Ido A
Clin J Gastroenterol; 2015 Feb; 8(1):1-9. PubMed ID: 25575848
[TBL] [Abstract][Full Text] [Related]
36. Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States.
Younossi ZM; Tampi R; Priyadarshini M; Nader F; Younossi IM; Racila A
Hepatology; 2019 Feb; 69(2):564-572. PubMed ID: 30180285
[TBL] [Abstract][Full Text] [Related]
37. [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
Zhu C; Zhou D; Fan J
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):81-4. PubMed ID: 26983471
[TBL] [Abstract][Full Text] [Related]
38. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Younossi Z; Tacke F; Arrese M; Chander Sharma B; Mostafa I; Bugianesi E; Wai-Sun Wong V; Yilmaz Y; George J; Fan J; Vos MB
Hepatology; 2019 Jun; 69(6):2672-2682. PubMed ID: 30179269
[TBL] [Abstract][Full Text] [Related]
39. Systematic Literature Review and Critical Appraisal of Health Economic Models Used in Cost-Effectiveness Analyses in Non-Alcoholic Steatohepatitis: Potential for Improvements.
Johansen P; Howard D; Bishop R; Moreno SI; Buchholtz K
Pharmacoeconomics; 2020 May; 38(5):485-497. PubMed ID: 31919793
[TBL] [Abstract][Full Text] [Related]
40. Knowledge, attitude, and practice toward COVID-19 among the public in three Gulf countries - a cross-sectional survey.
Almugeiren OM; Alanazi AK; Alnafea A; Alghufaili SM; Alkhafaji AB
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):4102-4112. PubMed ID: 35731081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
